Vogenx, Inc. Closes IPO Over-Allotment, Raises ~$93.44M

What Happened Vogenx, Inc. (VOGX) announced in an 8‑K that it completed the full exercise of the underwriter’s over‑allotment option related to its initial public offering. The company originally sold 6,250,000 shares at $13.00 per share on August 13, 2026, and, under an underwriting agreement with JonesTrading Institutional Services LLC dated August 11, 2026, the underwriter exercised a 45‑day option on August 19, 2026 to purchase an additional 937,500 shares at $13.00 per share. After the exercise, a total of 7,187,500 shares were issued, and gross proceeds from the Offering rose to approximately $93,437,500 (before underwriting discounts, commissions and estimated offering expenses).

Key Details

• Initial IPO (consummated Aug 13, 2026): 6,250,000 shares at $13.00/share → $81,250,000 gross.
• Over‑Allotment Option: 937,500 additional shares at $13.00/share → ~$12,187,500 gross, exercised and closed on Aug 19, 2026.
• Total shares sold after exercise: 7,187,500; total gross proceeds: ~$93,437,500 (pre‑fees/expenses).
• Underwriter: JonesTrading Institutional Services LLC; underwriting agreement dated Aug 11, 2026.

Why It Matters This filing confirms stronger-than-expected demand for Vogenx’s IPO (the underwriter fully exercised the option), increasing the company’s gross cash proceeds to roughly $93.4 million before fees. For investors, the larger cash balance can support operations, product development or growth initiatives, but note the reported figures are gross—actual net proceeds will be lower after underwriting discounts, commissions and offering expenses. The share count increase also means additional dilution compared with the original offering size.